secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)
CIK:        0000315545
Form:       8-K
Filed at:   2022-04-05T23:59:59+00:00
Accession:  0001493152-22-009078
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Provectus eliminates Series B Preferred Stock, increases Series D-1 authorized shares
--------------------------------------------------------------------------------

- Filed Certificate of Elimination for Series B Convertible Preferred Stock; all shares converted to common on Aug 25, 2021.
- Filed Certificate of Amendment increasing authorized Series D-1 Preferred Stock from 9,441,000 to 11,241,000 shares.
- Both actions effective March 30, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/315545/000149315222009078/0001493152-22-009078-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/315545/000149315222009078/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-009078

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer